HIGHLIGHTS
- who: Aisling R. Caffrey and collaborators from the University of of Medicine, Irvine, CA, United States have published the research: Impact of Clopidogrel on Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: a National Retrospective Cohort Study, in the Journal: (JOURNAL)
- how: The authors included patients already on clopidogrel as the inclusion of those newly initiated on P2Y12 inhibitors may introduce selection bias where those started on clopidogrel may have been less sick and/or physicians decided to be Page 11 of 27 more aggressive with antiplatelet therapy in the setting of the central nervous . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.